A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

May 18, 2020

Primary Completion Date

March 15, 2023

Study Completion Date

March 15, 2023

Conditions
Ulcerative Colitis
Interventions
DRUG

Mirikizumab

Administered IV and SC

Trial Locations (37)

3080

Seoul National University Hospital, Seoul

10029

Icahn Sch of Med at Mt. Sinai, New York

15224

UPMC Children's Hospital of Pittsburgh, Pittsburgh

19104

Children's Hospital of Philadelphia, Philadelphia

22031

Pediatrics Specialists of Virginia, Fairfax

23507

Children's Hospital of The King's Daughters Inc, Norfolk

30322

Emory University, Atlanta

30342

Children's Center for Digestive Health Care, LLC, Atlanta

41404

Kyungpook National University Medical Center Chilgok Hospital, Daegu

43205

The Abbigail Wexner Research Institute at Nationwide Children's Hospital, Columbus

45229

Cincinnati Childrens Hospital Medical Center, Cincinnati

46302

Riley Hospital for Children, Carmel

60637

University of Chicago Hospital, Chicago

63110

Washington University School of Medicine, St Louis

76104

Cook Children's Hospital, Fort Worth

77030

Texas Childrens Hospital, Houston

80045

Children's Hospital of Colorado, Denver

92868

Childrens Hospital of Orange County, Orange

94158

UCSF Medical Center at Mission Bay, San Francisco

98105

Seattle Children's Hospital Research Foundation, Seattle

2308765

Saiseikai Yokohamashi Tobu Hospital, Yokohama

3109601

Rambam Medical Center, Haifa

4920235

Schneider Children's Medical Center, Petah Tikva

06106

Connecticut Children's Medical Center, Hartford

02115

Boston Children's Hospital, Boston

02451

MGH for Children - Waltham, Waltham

07960

Goryeb Children's Hospital / Atlantic Health System, Morristown

T6G 1C9

University of Alberta Hospital, Edmonton

B3K 6R8

IWK Health Centre, Halifax

M5G 1X8

The Hospital for Sick Children, Toronto

Unknown

The Juliet Keidan Institute of Paediatric Gastroenterology and Nutrition; Shaare Zedek Medical Center, Jerusalem

830-0011

Kurume University Hospital, Kurume

330 8777

Saitama Children's Medical Center, Saitama-shi

113-8431

Juntendo University Hospital, Bunkyo-ku

113-8519

Tokyo Medical and Dental University Hospital, Bunkyō

157-8535

National Center For Child Health And Development, Setagaya-ku

160-0023

Tokyo Medical University Hospital, Shinjuku-ku

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04004611 - A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC) | Biotech Hunter | Biotech Hunter